Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDC1X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,613
Award facts
- Contract value 100% obligated
- $4,612.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections, with a contract ceiling value of $4,612.77 and an ultimate completion date of January 29, 2026. This competitively awarded, non-set-aside firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., regularly fulfills federal medical procurement needs for military and veteran healthcare systems through its extensive portfolio of delivery orders. The DLA Troop Support Medical IDC encompasses a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular task order for Zepbound, a diabetes medication, reflects the contractor's ongoing capability to efficiently supply essential pharmaceutical commodities required by military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FDC1X?
SPE2DR26FDC1X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FDC1X worth?
The government has obligated $4,613 on SPE2DR26FDC1X.
Is contract SPE2DR26FDC1X an order under another contract?
Yes. SPE2DR26FDC1X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDC1X competed?
The extent of competition for SPE2DR26FDC1X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award